Samsung partners with Lunit on AI for enhanced chest screenings

[Image courtesy of Samsung/Lunit]Samsung announced today that it entered into a supply contract with Lunit to utilize its AI-powered solutions for chest screenings.

Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound business, inked the deal. Lunit offers AI technology for cancer diagnostics and therapeutic. Together, they aim to enable faster and more accurate chest screenings for timely interventions with improved patient outcomes.

The companies plan to combine Lunit’s Insight CXR and Insight CXR Triage with Samsung’s computer-aided detection (CAD) AI. Lunit’s chest X-ray analysis technology and FDA-cleared AI triage solution enable the CAD AI to help radiologists manage patient exams by prioritizing those with suspected abnormalities.

Samsung Head of Digital Radiography, Eric Sumner, said chest X-rays are the “most requested exam in radiography.”

By partnering with Lunit, our Sa…

Read more
  • 0

Study backs Lunit’s AI-powered cancer diagnostics

Lunit’s chest X-ray AI analysis solution Lunit Insight CXR [Image courtesy of Lunit]Lunit recently announced the results of its study demonstrating the effectiveness of artificial intelligence (AI) solutions in cancer diagnostics.

The study, published in the journal Radiology, explored the impact of medical AI solutions’ accuracy on radiologists’ diagnostic determination. It used Lunit’s Insight CXR AI solution for chest X-ray analysis and showed that AI could improve radiologists’ performance.

There were 30 doctors involved in the study, including 20 board-certified radiologists with five to 18 years of expertise and 10 radiology residents with two to three years of training. The study assessed a total of 120 chest radiographs were assessed, with 60 obtained from patients with lung cancer and the remaining 60 showing no abnormalities. Seoul National University Hospital conducted the study from December 2015 to February 2021.

D…

Read more
  • 0

Lunit wins CE Mark for AI-based breast cancer detection software

Lunit announced today that it received CE Mark approval in Europe for its Lunit Insight MMG artificial intelligence-based software.

Insight MMG uses AI to analyze mammography images and provide the location of lesions that are suspicious for breast cancer, along with an abnormality score that reflects the probability of the existence of detected lesions. According to a news release, the software analyzes the images with 97% accuracy.

Lunit touted a recently published study in which AI alone showed 88.8% sensitivity in breast cancer detection, while radiologists alone showed 75.3%. When radiologists were aided by AI, their accuracy increased to 84.8%. This data came from a set of over 36,000 biopsy-proven, independent cancer-positive cases.

“Among the patients suspicious of breast cancer upon screening mammography, only 29% is actually diagnosed with cancer after a biopsy,” Lunit CEO Brandon Suh said in the release. “I am delighted to in…

Read more
  • 0